Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD)
[Characterization of de novo malignancies in liver transplantation]
Novos GLP-1 franchise has dominated to date, being first to market with a weight-loss GLP-1
GLP-1s may not cure Alzheimers as a monotherapy, but they are reshaping how we think about the interface of neurodegenerative disease etiology, metabolic health, vascular function and they likely will cement themselves as foundational tools in delaying cognitive decline across aging populations
US$ 25.78
US$ 21.12
US$ 20.30
US$ 28.53
US$ 28.81
US$ 29.13
